FAT4 and colorectal cancer: In line with our findings, in colorectal cancer, the downregulation of GSK-3-β upon FAT4 repression, while upregulation of its phosphorylated form, was observed, which was attributed to the PI3K-AKT pathway in colorectal cancer [13].